The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a $455,000.00 Firm Fixed Price Definitive Contract to Omicscraft LLC, a minority-owned, small disadvantaged business, for a cloud-based liquid-biopsy platform to support the Cancer Research Data Commons. This contract falls under the ISYSMET program, which focuses on the development of cloud-based pipelines for integrative analysis of multi-omics and imaging data. The...
The National Cancer Institute, a component of the Department of Health and Human Services' National Institutes of Health, awarded a $22,259 firm fixed price blanket purchase agreement call contract to 10X Genomics, Inc. for reagents and consumables. 10X Genomics will provide the requested products to support the NCI's biomedical research efforts from its location in Pleasanton, California over a one week period concluding on September 6, 2023. As one of the largest funders of cancer research...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $3 million firm fixed price purchase order to 10X Genomics, Inc. for genomics products and services. As the prime contractor, 10X Genomics will deliver its genome sequencing platforms and assays to support the agency's cancer research efforts from its Pleasanton, California location through the end of 2023. No subcontractors or set aside designations were indicated. This award draws on...
The National Institutes of Health's National Cancer Institute awarded a $24,324 firm fixed price blanket purchase agreement call contract to 10X Genomics, Inc. for biological products and services. As a leading developer and manufacturer of single-cell analysis solutions, 10X Genomics will support NCI's cancer research efforts under this six-month contract ending in late December 2023. No subcontractors or set aside designations were specified. The award is likely associated with NCI's BPA...
The National Cancer Institute (NCI) awarded a $2,000,000 firm fixed price contract to Omicscraft LLC, a minority-owned small disadvantaged business, to develop the ISYSMET: AI-Powered Platform for Integrative Analysis of Multimodal Data. This contract has a total small business set-aside. The platform will support biomedical research initiatives by providing cloud-based capabilities for integrative analysis of multi-omics and imaging data. Omicscraft LLC has previously delivered similar...
<p>The U.S. Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I firm-fixed-price contract to Mediomics LLC, a woman-owned small business, to develop novel tools for site-specific quantitative analysis of RNA modifications. The contract has a potential value of $248,357.00 and a completion date of June 18, 2018.</p>
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,324 firm fixed price blanket purchase agreement call contract to 10X Genomics, Inc. for biological kits. 10X Genomics will deliver its biological kits to support the National Cancer Institute's research efforts under this one month contract based in Pleasanton, California. No major subcontractors or set aside designations were identified. The award utilizes the National Institutes of...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $15,000 purchase order to 10X Genomics, Inc. for service agreement work. 10X Genomics will perform the services at its Pleasanton, California location from September 2023 through September 2024 under a firm fixed price contract. No additional details were provided on the scope of work requested under the solicitation. The National Cancer Institute supports research to advance cancer...
This is a definitive contract awarded by the National Cancer Institute, a civilian agency, to Biomedomics, Inc., a minority-owned, for-profit manufacturer, for $199,635.00 on a firm fixed price basis. The contract was set aside for small businesses and has an ultimate completion date of June 30, 2011. Biomedomics, Inc. has previously received federal contract and grant awards. Without additional details on the original solicitation, the specific products or services being delivered under this...
The National Institutes of Health's National Cancer Institute awarded a $24,257.50 firm fixed price blanket purchase agreement call contract to 10X Genomics, Inc., located in Pleasanton, California, to provide biological products and services. The contract term runs from October 31, 2023 through December 31, 2023. 10X Genomics will likely supply its genomic analysis platforms and assays to support the NIH-NCI's cancer research efforts. No major subcontractors or set aside designations were...
The National Cancer Institute (NCI) awarded a $300,000.00 Firm Fixed Price Definitive Contract to Newomics Inc. for the development of "OMICS-CHIPS FOR CTC ISOLATION AND MOLECULAR ANALYSIS". The contract has an ultimate completion date of September 12, 2014 and was awarded on September 13, 2013. This contract is not associated with any set-aside program. Newomics Inc. is a for-profit organization based in Moraga, California.